Risk of convulsions in children after monovalent H1N1 (2009) and trivalent influenza vaccines: a database study (Q30408504)

21 June 2017

Risk of convulsions in children after monovalent H1N1 (2009) and trivalent influenza vaccines: a database study (English)

1 reference

21 June 2017

1 reference

1 reference

2

Nick Andrews

1 reference

21 June 2017

1

Julia Stowe

1 reference

21 June 2017

5

Elizabeth Miller

1 reference

21 June 2017

Phil Bryan

3

1 reference

PubMed ID

22019757

21 June 2017

Suzie Seabroke

series ordinal

4

1 reference

PubMed ID

22019757

21 June 2017

language of work or name

English

0 references

publication date

20 October 2011

1 reference

21 June 2017

6

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

21 June 2017

29

1 reference

21 June 2017

51

1 reference

21 June 2017

9467-9472

1 reference

Risks of convulsion and aseptic meningitis following measles-mumps-rubella vaccination in the United Kingdom

21 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.029

MMR Vaccination and Febrile Seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.029

The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.029

A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.029

Decrease in Hospital Admissions for Febrile Seizures and Reports of Hypotonic-Hyporesponsive Episodes Presenting to Hospital Emergency Departments Since Switching to Acellular Pertussis Vaccine in Canada: A Report From IMPACT

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.029

Active surveillance of vaccine safety: a system to detect early signs of adverse events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.029

Oculo-respiratory syndrome: a new influenza vaccine-associated adverse event?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.029

Age-specific effectiveness of an oil-in-water adjuvanted pandemic (H1N1) 2009 vaccine against confirmed infection in high risk groups in England

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.029

No increased risk of febrile convulsions after seasonal influenza immunisation in UK

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.029

Idiopathic thrombocytopenic purpura and MMR vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.029

No evidence of an increase of bacterial and viral infections following Measles, Mumps and Rubella vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.029

Influenza A infection is an important cause of febrile seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.029

Influenza A and febrile seizures in childhood.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.029

Surveillance for influenza admissions among children hospitalized in Canadian immunization monitoring program active centers, 2003-2004.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.029

10.1016/J.VACCINE.2011.10.029

7 January 2021

Identifiers

DOI

1 reference

21 June 2017

1 reference

PubMed ID

22019757